- Home
- NERV vs LVLU Comparison
NERV vs LVLU Comparison
Compare NERV & LVLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- LVLU
- Stock Information
- Founded
- NERV 2007
- LVLU 1996
- Country
- NERV United States
- LVLU United States
- Employees
- NERV N/A
- LVLU N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- LVLU Catalog/Specialty Distribution
- Sector
- NERV Health Care
- LVLU Consumer Discretionary
- Exchange
- NERV Nasdaq
- LVLU Nasdaq
- Market Cap
- NERV 12.0M
- LVLU 10.8M
- IPO Year
- NERV 2014
- LVLU 2021
- Fundamental
- Price
- NERV $2.35
- LVLU $3.95
- Analyst Decision
- NERV Hold
- LVLU Hold
- Analyst Count
- NERV 1
- LVLU 1
- Target Price
- NERV $5.00
- LVLU $15.00
- AVG Volume (30 Days)
- NERV 41.4K
- LVLU 40.0K
- Earning Date
- NERV 11-04-2025
- LVLU 08-13-2025
- Dividend Yield
- NERV N/A
- LVLU N/A
- EPS Growth
- NERV N/A
- LVLU N/A
- EPS
- NERV 1.48
- LVLU N/A
- Revenue
- NERV N/A
- LVLU $292,337,000.00
- Revenue This Year
- NERV N/A
- LVLU N/A
- Revenue Next Year
- NERV N/A
- LVLU $2.53
- P/E Ratio
- NERV $1.58
- LVLU N/A
- Revenue Growth
- NERV N/A
- LVLU N/A
- 52 Week Low
- NERV $1.15
- LVLU $2.98
- 52 Week High
- NERV $3.00
- LVLU $28.05
- Technical
- Relative Strength Index (RSI)
- NERV 59.22
- LVLU 47.01
- Support Level
- NERV $2.26
- LVLU $3.67
- Resistance Level
- NERV $2.47
- LVLU $4.70
- Average True Range (ATR)
- NERV 0.15
- LVLU 0.35
- MACD
- NERV -0.01
- LVLU -0.00
- Stochastic Oscillator
- NERV 36.71
- LVLU 26.80
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About LVLU Lulu's Fashion Lounge Holdings Inc.
Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates majority of its revenue from customers based in the United States.